Sponsored By IQVIA Dec 15, 2025 8:00am Unmatched expertise in patient recruitment and retention One of the critical challenges in clinical trials is patient recruitment and retention. IQVIA Biotech’s comprehensive…
The FDA has qualified its first artificial intelligence tool to help drug developers evaluate fatty liver disease in their clinical trials. The agency gave a green light to the AI-Based…
Paradigm Health has raised $78 million as it works to revamp the clinical research ecosystem, while also announcing a deal to acquire Flatiron Health’s clinical research business unit. With the…
A new CRO called Avetra has emerged with a mission of modernizing clinical research operations by prioritizing transparency and faster study starts. Based in North Carolina, the self-proclaimed “next-gen” CRO…
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service provider in a deal valued at $204 million (PDF).…
Charles River Laboratories is laying off staff at one of its East Coast sites just over a week after announcing a strategic shift that will also see the CRO giant…
Bristol Myers Squibb is expanding a partnership with oncology organization Sarah Cannon Research Institute (SCRI), tapping into the institute’s community-based clinical trial network. BMS will plug its cancer pipeline into…
The board of Charles River Laboratories has completed a strategic review of the company, deciding to cut costs and shift investments into animal testing alternatives and other potential areas of…
Thermo Fisher Scientific is breaking out the big bills to score a clinical research treat. With $8.875 billion in cash, the life science giant is adding Clario Holdings to its…
Cancer health tech company Flatiron Health has unveiled six new blood cancer data sets that together comprise information from more than half a million patient records, the Roche subsidiary announced…